Continuation of emtricitabine/lamivudine within combination antiretroviral therapy following detection of the M184V/I HIV-1 resistance mutation.

TitleContinuation of emtricitabine/lamivudine within combination antiretroviral therapy following detection of the M184V/I HIV-1 resistance mutation.
Publication TypeJournal Article
Year of Publication2020
AuthorsStirrup O, Asboe D, Pozniak A, Sabin C, Gilson R, Mackie N, Tostevin A, Hill T, Dunn D and the UK HIV Drug Resistance Database and the UK Collaborative HIV Cohort
JournalHIV Med
URLhttps://www.ncbi.nlm.nih.gov/pubmed/31927793
DOI10.1111/hiv.12829